Publication|Articles|March 14, 2025
- Pharmaceutical Executive: March 2025
- Volume 45
- Issue 2
Pharmaceutical Executive: March 2025 Interactive Digital Edition
View the Pharmaceutical Executive March 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 year ago
High Impactabout 1 year ago
Mark Frohlich: A ‘Natural’ Leaderabout 1 year ago
FDA’s New Accelerated Approval Draft Guidanceabout 1 year ago
The Virtual Reality of Modern Pharma Sales and MarketingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Right–to-Try Does Not Undermine Clinical Trials
5